Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioactive enhanced adjuvant chemokine oligonucleotide nanoparticles (BEACONs) for mucosal vaccination against genital herpes.

Science immunology·2026
Same author

Analysis Of Salivary Herpesviruses Reveals Associations Between HHV-6 And Long COVID Severity.

medRxiv : the preprint server for health sciences·2026
Same author

A causal link between autoantibodies and neurological symptoms in long COVID.

Cell·2026
Same author

Freedom of scientific inquiry: reclaiming space for controversy.

Nature reviews. Immunology·2026
Same author

Intranasal Anti-CD3 Antibody Treatment Attenuates Post-COVID Neuroinflammation and Enhances Hippocampal Neurogenesis and Cognitive Function in Mice.

bioRxiv : the preprint server for biology·2026
Same author

Ocular Symptoms in Long COVID: A Cross-Sectional Study.

Clinical ophthalmology (Auckland, N.Z.)·2026

Related Experiment Video

Updated: Dec 9, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
08:26

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

1.9K

Pooling saliva to increase SARS-CoV-2 testing capacity.

Anne E Watkins1, Eli P Fenichel2, Daniel M Weinberger1

  • 1Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT 06510, USA.

Medrxiv : the Preprint Server for Health Sciences
|September 10, 2020
PubMed
Summary
This summary is machine-generated.

Pooling saliva samples for SARS-CoV-2 testing can expand capacity. While sensitivity decreases with larger pools, pooling is effective for surveillance in populations with varying prevalence rates.

More Related Videos

Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
11:11

Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots

Published on: February 11, 2022

4.9K
Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs
07:13

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs

Published on: April 9, 2021

4.5K

Related Experiment Videos

Last Updated: Dec 9, 2025

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling
08:26

Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample Pooling

Published on: June 23, 2022

1.9K
Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots
11:11

Efficient SARS-CoV-2 Quantitative Reverse Transcriptase PCR Saliva Diagnostic Strategy utilizing Open-Source Pipetting Robots

Published on: February 11, 2022

4.9K
Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs
07:13

Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs

Published on: April 9, 2021

4.5K

Area of Science:

  • Virology
  • Public Health

Background:

  • Expanding SARS-CoV-2 testing is crucial for managing the pandemic and informing reopening strategies.
  • Saliva offers a non-invasive method for detecting SARS-CoV-2 RNA, with potential for pooled testing to increase capacity.

Approach:

  • Investigated pooling saliva samples (5, 10, and 20 individuals) before RNA extraction and RT-qPCR detection.
  • Estimated sensitivity reductions of 7.41%, 11.11%, and 14.81% for pools of 5, 10, and 20, respectively.
  • Modeled the impact of pooling on RT-qPCR cycle threshold values.

Key Points:

  • Pooling saliva samples can decrease sensitivity, particularly with larger pool sizes.
  • The optimal pool size for SARS-CoV-2 saliva testing depends on the population prevalence.
  • Pools of 5 are most efficient in populations with >3% prevalence, while pools of 10 or 20 are better for lower prevalence surveillance.

Conclusions:

  • Saliva pooling is a viable strategy to increase SARS-CoV-2 testing capacity.
  • Strategic pooling can balance testing efficiency and sensitivity based on epidemiological context.
  • This approach supports scalable surveillance and management of the SARS-CoV-2 pandemic.